Interleukin 4 promotes anti-inflammatory macrophages that clear cartilage debris and inhibits osteoclast development to protect against osteoarthritis
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 229, 108784
Abstract
No abstract availableKeywords
Funding Information
- Department of Veterans Affairs (BX004713-01A1, I01RX002689)
This publication has 47 references indexed in Scilit:
- Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkinesNature Chemical Biology, 2012
- Orai1‐mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1The FASEB Journal, 2011
- Identification of a central role for complement in osteoarthritisNature Medicine, 2011
- Arthroscopy as a treatment for knee osteoarthritisBest Practice & Research Clinical Rheumatology, 2010
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Elevated serum levels of soluble interleukin-4 receptor in osteoarthritisOsteoarthritis and Cartilage, 2006
- Interleukin‐4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritisArthritis & Rheumatism, 1994
- Interleukin-4 Modulates Osteoclast Differentiation and Inhibits the Formation of Resorption Pits in Mouse Osteoclast CulturesBiochemical and Biophysical Research Communications, 1993
- Interleukin-4 as a potent inhibitor of bone resorptionBiochemical and Biophysical Research Communications, 1990